Key facts
- This page summarizes ARENA PHARMACEUTICALS INC's Form 4 filing for Longboard Pharmaceuticals, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 29 Jan 2024, 16:37.
ARENA PHARMACEUTICALS INC - 25 Jan 2024 Form 4 Insider Report for Longboard Pharmaceuticals, Inc.
- Reporting relationship
- Former 10% Owner
- Issuer ticker
- N/A
- Reported as of
- 25 Jan 2024
- Net transaction value
- -$96,479,595
- Reporting owner signature
- Arena Pharmaceuticals, Inc., By:/s/ Susan Grant, Assistant Secretary
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
ARENA PHARMACEUTICALS INC filed Form 4 for Longboard Pharmaceuticals, Inc. on 29 Jan 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$96,479,595.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LBPH
transaction
Voting Common Stock
Sale
- Transaction value
- $96,479,595
- Shares
- -3,978,540
- Change %
- -100%
- Price
- $24.25*
- Shares after
- 0
- Date
- 25 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
ARENA PHARMACEUTICALS INC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
The per share price is reported before fees.